Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo

Circulation

Volumn 110, Issue 19, 2004, Pages 3055-3061

  Nishida, Takahiro ^a   Shimokawa, Hiroaki ^a   Oi, Keiji ^a   Tatewaki, Hideki ^a   Uwatoku, Toyokazu ^a   Abe, Kohtaro ^a   Matsumoto, Yasuharu ^a   Kajihara, Noriyoshi ^a   Eto, Masataka ^a   Matsuda, Takehisa ^a   Yasui, Hisataka ^a   Takeshita, Akira ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Contractility; Hibernation; Ischemia; Regional blood flow

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; ENDOTHELIUM CELL; EXTRACORPOREAL LITHOTRIPSY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; UMBILICAL VEIN; UPREGULATION;

ANIMALS; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HIGH-ENERGY SHOCK WAVES; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEINS; RNA, MESSENGER; SUS SCROFA; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 20844460282     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000148849.51177.97     Document Type: Article

References (22)

1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-2018.
2. Gutersohn A, Caspari G. Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation. 2000;102(suppl):18.
3. Apfel RE. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer. 1982;45(suppl):140-146.
4. Maisonhaute E, Prado C, White PC, et al. Surface acoustic cavitation understood via nanosecond electrochemistry, part III: shear stress in ultrasonic cleaning. Ultrason Sonochem. 2002;9:297-303.
5. O'Konski MS, White FC, Longhurst J, et al. Ameroid constriction of the proximal left circumflex coronary artery in swine: a model of limited coronary collateral circulation. Am J Cardiovasc Pathol. 1987;1:69-77.
6. Roth DM, Maruoka Y, Rogers J, et al. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol. 1987;253:H1279-1288.
7. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5: 587-592.
8. Prinzen FW, Bassingthwaighte JB. Blood flow distributions by microsphere deposition methods. Cardiovasc Res. 2000;45:13-21.
9. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439.
10. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
11. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348:370-374.
12. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998; 97:1114-1123.
13. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998; 98:2800-2804.
14. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-966.
15. Auge BK, Preminger GM. Update on shock wave lithotripsy technology. Curr Opin Urol. 2002;12:287-290.
16. Weil LS Jr, Roukis TS, Weil LS, et al. Extracorporeal shock wave therapy for the treatment of chronic plantar fasciitis: indications, protocol, intermediate results, and a comparison of results to fasciotomy. J Foot Ankle Surg. 2002;41:166-172.
17. Fisher AB, Chien S, Barakat AI, et al. Endothelial cellular response to altered shear stress. Am J Physiol. 2001;281:L529-L533.
18. Wang FS, Wang CJ, Huang HJ, et al. Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun. 2001; 287:648-655.
19. Gotte G, Amelio E, Russo S, et al. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett. 2002;520:153-155.
20. Seidl M, Steinbach P, Worle K, et al. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics. 1994;32:397-400.
21. Wang CJ, Huang HY, Pai CH. Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg. 2002;41:16-22.
22. Millauer B, Wizigmann-Voos S, Schnurch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835-846.